Optimize market access and the commercial potential of your product.

With constantly evolving healthcare systems and increasing evidence scrutiny driven by ongoing budgetary pressures, traditional approaches to market access are no longer sufficient for ensuring commercial success. In the payer environment of today, market access is a critical component of both the clinical development phase as well as the post-marketing product life cycle.

Our expert team is here to help you devise actionable strategies that will optimize pricing and market access of your assets, both marketed and in clinical development, in the short and in the long-term, across the entire East Adriatic region. In order to achieve this goal, it is crucial to have insight into the following areas:

• Evolving competitive, regulatory, payer and clinical landscape in target therapy areas
• Key unmet needs and product value drivers
• Product value perceptions and identification of central evidence and value elements
• Reimbursement and price expectations

By supporting comprehension of the subsequent implications tied to your asset/s, we strive to help you achieve enhanced REGIONAL market access by:

• Timely assessing portfolio & asset opportunities
• Demonstrating value
• Accelerating access by reducing overall time-to-market
• Optimizing price, distribution channels and commercial performance in the long-term product life cycle
• Promoting collaborative communication and better understanding of payers, physicians and patients

We employ both primary and secondary research methodologies and have a regionally solidified network of regulators, payers and clinical stakeholders across a variety of therapy areas and settings in eight key markets of the East Adriatic. Our research offering includes the use of traditional and innovative, validated quantitative and qualitative methodologies that can be uniquely tailored for each individual project.

Online
Qualitative and quantitative surveys
Bulletin boards
VC focus groups, payer/KOL panels, advisory boards

Telephone studies
1:1 in-depth interviews
DYADs – in-depth interviews with 2 participating stakeholders